These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32817662)

  • 21. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'.
    Lavezzo E; Franchin E; Ciavarella C; Cuomo-Dannenburg G; Barzon L; Del Vecchio C; Rossi L; Manganelli R; Loregian A; Navarin N; Abate D; Sciro M; Merigliano S; De Canale E; Vanuzzo MC; Besutti V; Saluzzo F; Onelia F; Pacenti M; Parisi SG; Carretta G; Donato D; Flor L; Cocchio S; Masi G; Sperduti A; Cattarino L; Salvador R; Nicoletti M; Caldart F; Castelli G; Nieddu E; Labella B; Fava L; Drigo M; Gaythorpe KAM; ; Brazzale AR; Toppo S; Trevisan M; Baldo V; Donnelly CA; Ferguson NM; Dorigatti I; Crisanti A;
    Nature; 2020 Aug; 584(7821):425-429. PubMed ID: 32604404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
    Stringhini S; Wisniak A; Piumatti G; Azman AS; Lauer SA; Baysson H; De Ridder D; Petrovic D; Schrempft S; Marcus K; Yerly S; Arm Vernez I; Keiser O; Hurst S; Posfay-Barbe KM; Trono D; Pittet D; Gétaz L; Chappuis F; Eckerle I; Vuilleumier N; Meyer B; Flahault A; Kaiser L; Guessous I
    Lancet; 2020 Aug; 396(10247):313-319. PubMed ID: 32534626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China.
    Zhang W; Cheng W; Luo L; Ma Y; Xu C; Qin P; Zhang Z
    Emerg Infect Dis; 2020 Aug; 26(8):1924-1926. PubMed ID: 32453686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 epidemic: Disease characteristics in children.
    She J; Liu L; Liu W
    J Med Virol; 2020 Jul; 92(7):747-754. PubMed ID: 32232980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis.
    Dawood FS; Ricks P; Njie GJ; Daugherty M; Davis W; Fuller JA; Winstead A; McCarron M; Scott LC; Chen D; Blain AE; Moolenaar R; Li C; Popoola A; Jones C; Anantharam P; Olson N; Marston BJ; Bennett SD
    Lancet Infect Dis; 2020 Nov; 20(11):1255-1262. PubMed ID: 32738203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The first 2 months of the SARS-CoV-2 epidemic in Yemen: Analysis of the surveillance data.
    Al-Waleedi AA; Naiene JD; Thabet AAK; Dandarawe A; Salem H; Mohammed N; Al Noban M; Bin-Azoon NS; Shawqi A; Rajamanar M; Al-Jariri R; Al Hyubaishi M; Khanbari L; Thabit N; Obaid B; Baaees M; Assaf D; Senga M; Bashir IM; Mahmoud N; Cosico R; Smith P; Musani A
    PLoS One; 2020; 15(10):e0241260. PubMed ID: 33119720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
    Ouldali N; Pouletty M; Mariani P; Beyler C; Blachier A; Bonacorsi S; Danis K; Chomton M; Maurice L; Le Bourgeois F; Caseris M; Gaschignard J; Poline J; Cohen R; Titomanlio L; Faye A; Melki I; Meinzer U
    Lancet Child Adolesc Health; 2020 Sep; 4(9):662-668. PubMed ID: 32622376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and transmission dynamics of COVID-19 in two Indian states.
    Laxminarayan R; Wahl B; Dudala SR; Gopal K; Mohan B C; Neelima S; Jawahar Reddy KS; Radhakrishnan J; Lewnard JA
    Science; 2020 Nov; 370(6517):691-697. PubMed ID: 33154136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
    Elrashdy F; Redwan EM; Uversky VN
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics.
    Kamel Boulos MN; Geraghty EM
    Int J Health Geogr; 2020 Mar; 19(1):8. PubMed ID: 32160889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review.
    Juan J; Gil MM; Rong Z; Zhang Y; Yang H; Poon LC
    Ultrasound Obstet Gynecol; 2020 Jul; 56(1):15-27. PubMed ID: 32430957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of SARS-CoV-2 on hospital acquired infection rates in the United States: Predictions and early results.
    McMullen KM; Smith BA; Rebmann T
    Am J Infect Control; 2020 Nov; 48(11):1409-1411. PubMed ID: 32621857
    [No Abstract]   [Full Text] [Related]  

  • 35. Estimation of Coronavirus Disease Case-Fatality Risk in Real Time.
    Ge Y; Sun S
    Emerg Infect Dis; 2020 Aug; 26(8):1922-1923. PubMed ID: 32315282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Phase of the COVID-19 Outbreak in Hungary and Post-Lockdown Scenarios.
    Röst G; Bartha FA; Bogya N; Boldog P; Dénes A; Ferenci T; Horváth KJ; Juhász A; Nagy C; Tekeli T; Vizi Z; Oroszi B
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32629880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Data-driven study of the COVID-19 pandemic via age-structured modelling and prediction of the health system failure in Brazil amid diverse intervention strategies.
    Canabarro A; Tenório E; Martins R; Martins L; Brito S; Chaves R
    PLoS One; 2020; 15(7):e0236310. PubMed ID: 32730352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden of Illness in Households With Severe Acute Respiratory Syndrome Coronavirus 2-Infected Children.
    Teherani MF; Kao CM; Camacho-Gonzalez A; Banskota S; Shane AL; Linam WM; Jaggi P
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):613-616. PubMed ID: 32780809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling the role of asymptomatics in infection spread with application to SARS-CoV-2.
    Dobrovolny HM
    PLoS One; 2020; 15(8):e0236976. PubMed ID: 32776963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.